[Federal Register Volume 59, Number 122 (Monday, June 27, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-15526]


[[Page Unknown]]

[Federal Register: June 27, 1994]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES
 

National Heart, Lung, and Blood Institute; Closed Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
Heart, Lung, and Blood Special Emphasis Panel (SEP) meetings:

    Name of SEP: Gene Therapy for Hemophilias A and B.
    Date: July 12-13, 1994.
    Time: 8:00 p.m.
    Place: Holiday Inn Bethesda, Bethesda, Maryland.
    Contact Person: Eric H. Brown, Ph.D., Scientific Review 
Administrator, 5333 Westbard Avenue, Room 5A09, Bethesda, Maryland 
20892, (301) 594-7484.
    Purpose/Agenda: To review and evaluate grant applications.

    Name of SEP: In Vitro Inactivation of Viruses in Blood 
Components.
    Date: July 21-22, 1994.
    Time: 7:00 p.m.
    Place: Holiday Inn Chevy Chase, Chevy Chase, Maryland.
    Contact Person: Andre J. Premen, Ph. D., Scientific Review 
Administrator, 5333 Westbard Avenue, Room 5A10, Bethesda, Maryland 
20892, (301) 594-7481.
    Purpose/Agenda: To review and evaluate grant applications.

    Name of Sep: Demonstrate and Education Research Application.
    Date: July 27-28, 1994.
    Time: 9:00 p.m.
    Place: Stouffer Concourse Hotel, Arlington, Virginia.
    Contact Person: Louise P. Corman, Ph.D., Scientific Review 
Administrator, 5333 Westbard Avenue, Room 548, Bethesda, Maryland 
20892, (301) 594-7452.
    Purpose/Agenda: To review and evaluate grant applications.

    These meetings will be closed in accordance with the provisions 
set forth in sec. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personnel 
privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health)

    Dated: June 21, 1994.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 94-15526 Filed 6-24-94; 8:45 am]
BILLING CODE 4140-01-M